Madrigal Pharmaceuticals
MDGL
#1779
Rank
NZ$20.29 B
Marketcap
NZ$880.13
Share price
0.95%
Change (1 day)
79.45%
Change (1 year)

Earnings for Madrigal Pharmaceuticals (MDGL)

Earnings in 2026 (TTM): -NZ$0.49 Billion

According to Madrigal Pharmaceuticals 's latest financial reports the company's current earnings are NZ$1.13 Billion. In 2025 the company made an earning of -NZ$0.46 Billion, an increase over its 2024 earnings that were of -NZ$0.77 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Madrigal Pharmaceuticals from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.49 Billion7.14%
2025 -NZ$0.46 Billion-41.05%
2024 -NZ$0.77 Billion25.02%
2023 -NZ$0.62 Billion23.86%
2022 -NZ$0.5 Billion20.24%
2021 -NZ$0.42 Billion17.25%
2020 -NZ$0.36 Billion117.61%
2019 -NZ$0.17 Billion189.45%
2018 -NZ$55.9 Million3.85%
2017 -NZ$53.83 Million25.71%
2016 -NZ$42.82 Million-50.81%
2015 -NZ$87.05 Million-39.14%
2014 -NZ$0.15 Billion-4.12%
2013 -NZ$0.15 Billion
2011 -NZ$77.4 Million23.13%
2010 -NZ$62.86 Million-145.81%
2009 NZ$0.13 B-185.95%
2008 -NZ$0.16 Billion41.52%
2007 -NZ$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.28 Billion-43.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$30.93 Million-93.58%๐Ÿ‡บ๐Ÿ‡ธ USA